4. Huang, S., et al. “Nanoparticle Adjuvant Design Enhances Germinal Center Responses Targeting Conserved Subdominant Epitopes for Pan‐Coronavirus Vaccine Development“, Advanced Science, 2025. doi: https://doi.org/10.1002/advs.202512100
3. Kang, X., Cheemalamarri, S. K., Yin, Q. “Organoid: a promising solution to current challenges in cancer immunotherapy”, npj Biomedical Innovations, 2025. (In press)
2. Narayan, O. P., Dong, J., Huang, M., Chen, L., Liu, L., Nguyen, V., Dozic, A.V,, Liu, X., Wang, H., Yin, Q., Tang, X., Guan, J. “Reversible light-responsive protein hydrogel for on-demand cell encapsulation and release”, Acta Biomaterialia, 2025, 193, 202-214.
1. Udeshi, N. D., Xu, C., Jiang, Z., Gao, S., Yin, Q., Luo, W., Carr, S. A., Davis, M. M., Li, J. “Cell-surface Milieu Remodeling in Human Dendritic Cell Activation“, J. Immunol., 2024, ji2400089.
Prior UT
First author or co-first author:
11. Yin. Q. #; Luo, W. # (co-first author); Mallajosyula, V.; Bo, Y.; Guo, J.; Xie, J.; Sun, M.; Verma R.; Li, C.; Constant, C.; Wagar, L.; Li, J.; Sola, E.; Gupta, N.; Wang, C.; Kask, O.; Chen, X.; Yuan, X.; Rao, J.; Chien, Y.; Cheng, J.; Pulendran, B.; Davis, MM. “A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of Influenza and SARS-CoV-2“, Nature Materials, 2023, 22, 380-390.
Highlighted: News&Views “Immunostimulatory nanoparticles go viral” in Nature Materials, 2023, 22, 273-275”.
10. Yin, Q.; Yu, W.; Grzeskowiak, C.; Li, J.; Huang, H.; Guo, J.; Chen, L.; Wang, F.; Zhao, F.; von Boehmer, L.; Metzner, T.; Leppert, J.; Chien, Y-H.; Kuo, C.; Davis, MM. “Nanoparticle-enabled innate immune stimulation activates endogenous tumor infiltrating T cells with broad antigen specificities”, Proceedings of the National Academy of Sciences, 2021, 118 (21) e2016168118.
9. Yin, Q.; Tang, L.; Cai, K.; Yang, X.; Yin, L.; Zhang, Y.; Dobrucki, LW.; Helferich, WG.; Fan, TM.; Cheng, J. “Albumin as a ‘Trojan Horse’ for Polymeric Nanoconjugates Transendothelial Transport across Tumor Vasculatures for Improved Cancer Targeting“, Biomaterials Science, 2018, 6, 1189–1200.
8. Yin, Q.#; Tang, L. # (co-first author); Tong, R.; Sternberg, R.; Yang, X.; Dobrucki, LW.; Borst, LB.; Kamstock, DA.; Cai, K.; Song, Z.; Helferich, WG.; Cheng, J.; Fan, TM. “Pamidronate Functionalized Doxorubicin-Polylactide Nanoconjugates for Targeted Therapy of Focal Skeletal Malignant Osteolysis“, Proceedings of the National Academy of Sciences, 2016, 113, E4601-4609.
Highlighted: NIH Director’ Blog, FierceBiotech, Noodles, EurekAlert!, Technology.org, Nanotechnology Now, Drug Discovery & Development, BioschienceTechnology, Azonano, Science Daily, Laboratory Journal, Phys.org, Nanowerk, Engineering at Illinois.
7. Azzi, J. #; Yin, Q.# (co-first author); Ohori, S.; Tang, L.; Cai, K.; Abdoli, R.; Uehara, M.; McGrath, M.; Kefaloyianni, E.; Ichimura, T.; Petr, J.; Sun, Q.; Kwon, M.; Cheng, J. ;Abdi, R. “Targeted delivery of immunomodulators to lymph nodes“, Cell Reports,2016, 15, 1202-1213.
6. Yin, Q.; Yin, L.; Wang, H.; Cheng, J. “Synthesis and biomedical applications of functional poly(α-hydroxy acids) via ring-opening polymerization of O-carboxyanhydrides”, Accounts of Chemical Research, 2015, 48, 1777-1787.
5. Tang, L.#; Yin, Q. # (co-first author); Xu, Y.; Zhou, Q.; Cai, K.; Yen, J.; Dobrucki, LW; Cheng, J.“Bioorthogonal Oxime Ligation Mediated In Vivo Cancer Targeting“, Chemical Science, 2015, 6, 2182-2186.
4. Yin, Q.; Tong, R.; Yin, L.; Fan, TM.; Cheng, J. “Anticancer Camptothecin-N-Poly(lactic acid) Nanoconjugates with Facile Hydrolysable Linker“, Polymer Chemistry, 2014, 5, 1581-1585.
3. Yin, Q.; Yap, FY.; Yin, L.; Ma, L.; Zhou, Q.; Dobrucki, LW.; Fan, TM.; Gaba, RC.; Cheng, J. “Poly(iohexol) Nanoparticles As Constrast Agents for In Vivo X-ray Computed Tomography Imaging“, Journal of American Chemical Society, 2013, 135, 13620–13623.
2. Yin, Q.; Tong, R.; Xu, Y.; Fan, TM.; Cheng, J. “Drug-Initiated Ring-Opening Polymerization of O-Carboxyanhydrides for the Synthesis of Drug-Poly(O-Carboxyanhydride) Nanoconjugate Anticancer Delivery Systems“, Biomacromolecules, 2013, 14, 920–929.
1. Li, L. #; Yin, Q.# (co-first author); Cheng, J.; Lu, Y. “Polyvalent Mesoporous Silica Nanoparticle-Aptamer Bioconjugates Target Breast Cancer Cells“, Advanced Healthcare Materials, 2012, 1, 567-572.
Co-author:
24. Luo, W.; Yin, Q. “B cell response to vaccination” Immunological Investigations, 2021, 50, 780-801.
23. Sun, S., Luo, L., Liang, W., Yin, Q., Guo, J., Rush, A. M., Lv, Z., Liang, Q., Fischbach, M. A., Sonnenburg, J. L., Dodd, D., Davis, M. M., Wang, F. “Bifidobacterium alters the gut microbiota and modulates the functional metabolism of T regulatory cells in the context of immune checkpoint blockade”, Proceedings of the National Academy of Sciences, 2020, 117, 27509-27515.
22. Roth, G. A., Gale, E. C., Alcántara-Hernández, M., Luo, W., Axpe, E., Verma, R., Yin, Q., Yu, A.C., Hernandez, H.A., Maikawa, C.L., Smith, A. A, Davis, M.M., Pulendran,B., Idoyaga, J., Appel, E.A. “Injectable hydrogels for sustained codelivery of subunit vaccines enhance humoral immunity”, ACS central science, 2020, 6, 1800-1812.
21. Fernandes, R. A., Su, L., Nishiga, Y., Ren, J., Bhuiyan, A. M., Cheng, N., Kuo, C. J., Picton, L. K., Ohtsuki, S., Majzner, R. G., Rietberg, S. P., Mackall, C. L., Yin, Q., Ali, L. R., Yang, X., Savvides, C. S., Sage, J., Dougan, M., Garcia, K. C. “Immune receptor inhibition through enforced phosphatase recruitment”, Nature, 2020, 586, 779–784.
20. Wang, F.; Yin, Q.; Chen, L.; Davis M. M. “Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade”, Proceedings of the National Academy of Sciences, 2018, 151, 157-161.
19. Wang, H.; Wang, R.; Cai, K.; He, H.; Liu, Y.; Yen, J.; Wang, Z.; Xu, M.; Sun, Y.; Zhou, X.; Yin, Q.; Tang, L.; Dobrucki, I.T.; Dobrucki, L.W.; Chaney, E.J.; Boppart, S.A.; Fan, T.M.; Lezmi, S.; Chen, X.; Yin, L.; Cheng, J. “Selective In Vivo Metabolic Cell Labeling Mediated Cancer Targeting”, Nature Chemical Biology, 2017, 13, 415-424.
18. Wang, R.; Zhang, J.; Yin, Q.; Xu, Y.; Cheng, J.; Tong, R. “Controlled Ring-Opening Polymerization of O-Carboxyanhydrides Using β-Diiminate Zinc Catalyst”, Angew. Chem. Int. Ed., 2016, 55, 13010-13014.
17. Xing, H.; Xu, W.; Hwang, K.; Wu, P.; Yin, Q.; Li, Z.; Cheng, J.; Lu, Y. “The Effects of Spacer Length and Composition on Aptamer-Mediated Cell-Specific Targeting with Nanoscale PEGylated Liposomal Doxorubicin”, CHEMBIOCHEM, 2016, 17, 1111-1117.
16. Tang, L.; Tong, R; Coyle, V; Yin, Q; Pondenis, H; Borst, L; Cheng, J; Fan, T. “Targeting Tumor Vasculature with Aptamer Functionalized Doxorubicin-Polylactide Nanoconjugates for Enhanced Cancer Therapy”, ACS Nano, 2015, 9, 5072-5081.
15.Zhang, Y.; Yin, Q.; Yen, J.; Li, J.; Ying, H.; Wang, H.; Hua, Y.; Chaney, E.; Boppart, S.; Cheng, J. “Non-Invasive, Real-Time Reporting Drug Release In Vitro and In Vivo”, Chemical Communications, 2015, 51, 6948-6951.
14. Cai, K.; He, X.;Song, Z.; Yin, Q.; Zhang, Y.; Uckun, F.; Jiang, C.; Cheng, J. “Dimeric Drug Polymeric Nanoparticles with Exceptionally High Drug Loading and Quantitative Loading Efficiency”, Journal of American Chemical Society, 2015, 137, 3458-3461.
13. Yin, L.; Chen, Y.; Zhang, Z.; Yin, Q.; Zheng, N.; Cheng, J. “Biodegradable Micelles Capable of Mannose-Mediated Targeted Drug Delivery to Cancer Cells”, Macromolecular Rapid Communications, 2015, 36, 483-489.
12. Cai, K.; Yen, J.; Yin, Q.; Liu, Y.; Song, Z.; Lezmi, S.; Zhang, Y.; Yang, X.; Helferich, WG.; Cheng, J. “Redox-Responsive Self-Assembled Chain-Shattering Polymeric Therapeutics”, Biomaterials Science, 2015, 3, 1061-1065.
11. Gauthier, M.; Yin, Q.; Cheng, J.; O’Brien, WD. “Design of albumin-coated microbubbles loaded with polylactide nanoparticles”, J. Ultrasound Medicine, 2015, 34, 1363-1372.
10. Tang, L.; Yang, X.; Yin, Q.; Cai, K.; Wang, H.; Chaudhury, I.; Yao, C.; Zhou, Q.; Kwon, M.; Hartman, JA.; Dobrucka, IT; Dobrucki, LW; Borst, LB; Lezmi, S.; Helferich, WG.; Ferguson, AL; Fan, TM.; Cheng, J. “Investigating the optimal size of anticancer nanomedicine”, Proceedings of the National Academy of Sciences, 2014, 111, 15344-15349.
9. Zhang, Y.; Yin, Q.; Yin, L.; Ma, L.; Tang, L.; Cheng, J. “Chain-Shattering Polymeric Therapeutics with On-Demand Drug-Release Capability”, Angew Chem. Int. Ed., 2013, 52, 6435-6439.
8. Wang, H.;Tang, L.; Tu, C.; Song, Z.; Yin, Q.; Yin, L.; Zhang, Z.; Cheng, J. “Redox-Responsive, Core-Cross-Linked Micelles Capable of On-Demand, Concurrent Drug Release and Structure Disassembly ”, Biomacromolecules, 2013, 14, 3706–3712.
7. Zhang, Y.; Yin, Q.; Lu, H.; Xia, H.; Lin, Y.; Cheng, J. “PEG-Polypeptide Dual Brush Block Copolymers: Synthesis and Application in Nanoparticle Surface PEGylation”, ACS Macro Letter, 2013, 2, 809-813.
6. Xing, H.; Tang, L.; Yang, X.; Hwang, K.; Wang, W.; Yin, Q.; Dobrucki, W.; Yasui, N.; Katzenellenbogen, JA; Helferich, WG; Cheng, J.; Lu, Y. “Selective delivery of an anticancer drug with aptamer-functionalized liposomes to breast cancer cells in vitro and in vivo”, J. Mater. Chem. B, 2013, 1, 5288-5297.
5. Uckun, F.M.; Qazi, S.; Cely, I.; Sahin, K.; Shahidzadeh, A.; Jan, S.; Tuzcu, M.; Ilhan, N.; Ozercan, I.; Yin, Q.; Gaynon, P.; Termuhlen, A.; Cheng, J.; Yiv, S.H.; “Nanoscale liposomal formulation of a SYK P-site inhibitor against B-precursor leukemia.”, Blood, 2013, 121, 4348-4354.
4. Tang, L.; Yang, X.; Dobrucki, LW; Chaudhury, I.; Yin, Q.; Yao, C.; Lezmi, S.; Helferich, WG Fan, TM; Cheng, J. “Apatmer-functionalized, ultra-small, monodisperse silica nanoconjugate for targeted dual-modal imaging of lymph nodes with metastatic tumors”, Angew Chem. Int. Ed., 2012, 124, 12893-12898.
3. Tang, L.; Azzi, J.; Kwon, M.; Mounayar, M.; Tong, R.; Yin, Q.; Moore, RF.; Skartsis, N.; Fan, TM.; Abdi, R.; Cheng, J.“Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A”, Journal of Transplantation, 2012, Article ID 896141.
2. Chen, K.; Tang, L.; Garcia, MA; Wang, H.; Lu, H.; Lin, WY; Hou, S.; Yin, Q.; Shen, CKF.; Cheng, J.; Tseng, HR. “The therapeutic efficacy of camptothecin-encapsulated supramolecular nanoparticles”, Biomaterials, 2012, 33, 1162-1169.
1. Cely, I.; Yiv, S.; Yin, Q.; Shahidzadeh, A.; Tang, L.; Cheng, J.; Uckun, F.M. “Targeting Mantle Cell Lymphoma with Anti-SYK Nanoparticles”, J. Anal. Oncology, 2012, 1, 1-9.